Skip to main content

Table 1 Demographic and baseline characteristics of 69 localized scleroderma (LS) subjects and 71 healthy control subjects who were included in the plasma analysis

From: Interferon-gamma inducible protein-10 as a potential biomarker in localized scleroderma

Characteristics LS patients Healthy controls
(number = 69) (number = 71)
  number (%) number (%)
Female 46 (66.7) 38 (54)
Caucasian 63 (91) unknown
  Median (IQR) Median (IQR)
Age at plasma sample in years 12.5 (10.0 to 16.0) 3 (2.0 to 9.0)
Age at disease onset in years 9 (7.0 to 11.0) ---
LS subtype   
  Linear scleroderma trunk/extremity 26 (37.7) ---
  Linear scleroderma head (En coup de sabre / Parry Romberg Syndrome) 14 (20.3) ---
  Mixed morphea 9 (13.0) ---
  Generalized morphea 8 (11.6) ---
  Plaque (circumscribed superficial) morphea 5 (7.2) ---
  Deep (circumscribed deep) morphea 4 (5.8) ---
  Pansclerotic morphea 1 (1.4) ---
Clinical measures of activity: median (IQR)  
  PGA-A 41.0 (29.0 to 62.0) ---
  mLoSSI 6.0 (3.0 to 13.0) ---
  1. IQR, interquartile range; mLoSSI, modified Localized Scleroderma Skin Score; PGA-A, physician global assessment of activity.